| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |